FDA Recalls Compounded Fentanyl Citrate IV Bags Due to Sterility Concerns
Fagron Compounding Services is recalling 1,330 units of fentanyl Citrate IV bags (Lot C274-000040409) distributed in Pennsylvania due to lack of sterility assurance. The product may pose a contamination risk if administered.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for a sterile injectable drug with lack of sterility assurance. Although no illnesses or injuries have been reported, the hazard is high-risk and affects patient safety if the product was contaminated and administered.
Plain-English summary
Fagron Compounding Services is recalling fentanyl Citrate in Sodium Chloride 1600mcg/100mL IV bags. The recall affects 1,330 units of Lot #C274-000040409 (expiration date March 2025) distributed in Pennsylvania.
The recall is due to lack of assurance of sterility. As a compounded injectable medication, the product must meet strict sterility standards to prevent contamination and potential patient harm.
Healthcare facilities that received these bags should discontinue use immediately and verify whether the affected product was administered to any patients. Any patients who received medication from this product should contact their healthcare provider for evaluation and monitoring.
The recalled product
- Product
- fentaNYL Citrate In Sodium Chloride 1600mcg/100mL (16 mcg per mL) CII, Single use 100mL IV Bag, Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67726 Bar Code 71266-5060-01
- Manufacturer
- Fagron Compounding Services
- Category
- Drug — Injectable Medication
- Affected units
- 1,330
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # C274-000040409
- Exp 03/22/2025
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Fagron Compounding Services
See all →- HighFagron norepinephrine 32 mg bags recalled over sterility and port part
FDA (Drugs) · 2026-04-15
- HighFagron vancomycin 1.5 gram bags recalled over sterility and detaching port part
FDA (Drugs) · 2026-04-15
- HighFagron vancomycin infusion bags recalled over sterility and detaching port part
FDA (Drugs) · 2026-04-15
- HighFagron vancomycin 1.25 gram bags recalled over sterility and detaching port part
FDA (Drugs) · 2026-04-15
- HighFagron norepinephrine infusion bags recalled over sterility and detaching port part
FDA (Drugs) · 2026-04-15
Same hazard · contamination
See all →- HighFresenius Recalls Granuflo Dry Acid Concentrate Due to Discoloration
FDA (Devices) · 2026-09-09
- HighMedline Recalls Cataract Preop Kits with Potentially Contaminated Applicators
FDA (Devices) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- HighMedline Blood Culture Kits Recalled Due to Incomplete Applicator Seals
FDA (Devices) · 2026-09-09
- HighMedline Ortho Aspiration Kits Recalled for Potential Contamination
FDA (Devices) · 2026-09-09